Solubility Methods for ML-era Drug Design & Development COMPARISON REPORT Solubility Methods for ML-era Drug Design & Development Implications for predictive model development across modalities and stages   The quality of a predictive model is bounded by the quality of the data it learns from. In solubility prediction, dataset heterogeneity

Preclinical α-FORMULATION™ Screen Introduction Preclinical formulation development plays a crucial role in pharmaceutical research, laying the foundation for successful drug discovery and clinical progression. Getting the formulation right early helps mitigate development risks and avoids costly reformulation in later stages. The key factor for formulation success at this early stage

Overcoming Challenges in HPAPI Analysis with Miniaturization Rapid Insights Highly potent active pharmaceutical ingredients (HPAPIs) play a pivotal role in modern drug development, especially in oncology, inflammatory diseases, and antiviral therapeutics where their therapeutic effects at exceptionally low doses bring significant advantages. However, the potency of HPAPIs introduces a challenge

Mitigating Salt Disproportionation Risks Rapid Insights Salt formation is a well-established strategy for increasing the solubility of ionizable drug candidates; however, the possible conversion of salts to their free acid or base forms through disproportionation can have detrimental effects on the stability, manufacturability and regulatory compliance of a drug product

Jumpstarting Formulation Development Rapid Insights Many formulators we speak with rank time pressure as the primary challenge in their programs. The main barriers often cited include the limited amount of available compound for initial formulation screening, filling in information gaps related to the API, and the complex analytical methods required

The Data Package You Wish You Had but Don’t Have Time to Collect Rapid Insights An impurity formed during a chemical reaction ultimately needs to be purged. As you aim for simplification, efficiency, and minimizing operations in scaling up the chemistry, this challenge becomes magnified the longer it persists. While

Unleashing Bioavailability: A Synergistic Approach for the Race Against Disproportionation Rapid Insights In our latest joint white paper, we explore a breakthrough strategy to improve the bioavailability of poorly soluble APIs together with Microsize. For those in the pharmaceutical industry, improving the bioavailability of APIs is a critical challenge. We

The Critical Role of Solubility in Saving Time and Cost in the Development of Antibody-Drug Conjugates (ADCs) Rapid Insights Antibody-Drug Conjugates (ADCs) combine the specificity of monoclonal antibodies with the potent cytotoxic effects of small molecule drugs. Due to the sophisticated nature of these new modalities, both the challenges and

What is ‘True Solubility’? Rapid Insights While the so-called shake-flask method is considered the industry-standard for measuring accurate solubility, there actually exists no standardized protocol. Attempts by international working groups have been made in the past on consensus recommendations for improving data quality of solubility measurement (1), however, these are

Solubility in Chemical Synthesis Process Scaling Rapid Insights The costs and timelines for production are tied to the complexity of the chemistry and the resources necessary for manufacturing. When advancing an asset by developing the initial chemical synthesis into a scalable process, the arguably biggest impact on reducing costs, complexity,

Formulate First Time Right Rapid Insights A recent conversation with an industry veteran highlighted that pharmaceutical R&D costs can increase more than 15-fold and timelines can extend an additional 2 years due to an unanticipated change in formulation strategy. Since this has the potential to derail an entire program or